US equities |
INTC $119.13 ▼-0.17% MU $1,074.89 ▲+0.00% META $728.08 ▲+0.00% NVDA $233.95 ▲+0.00% TSLA $370.59 ▲+0.00% AMD $633.91 ▲+0.00% JNJ $256.03 ▲+0.00% SPCX $158.96 ▲+0.00%
FinancialContent

Bio-Rad Laboratories, Inc. Class A Common Stock (NY:BIO)

369.14 UNCHANGED
Delayed Quote Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bio-Rad Laboratories, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
Top 5 Health Care Stocks That Could Lead To Your Biggest Gains In May ↗
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
News headline image
Bio-Rad to Participate in Fireside Chat During 2023 RBC Capital Markets Global Healthcare Conference
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Stocks Roar Back To Life; Still Pacing For Weekly Loss ↗
Rebounding bank stocks, stellar Apple earnings, and a blowout jobs report are all helping stocks move significantly higher Friday afternoon. 
Via Talk Markets
News headline image
Recap: Bio-Rad Laboratories Q1 Earnings ↗
 
Via Benzinga
News headline image
Bio-Rad Reports First-Quarter 2023 Financial Results
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Golden Cross Appears Before Bio-Rad Laboratories Investors ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 16, 2023 ↗
Companies Reporting Before The Bell • RELX (NYSE:RELX) is estimated to report earnings for its Fiscal Year 2022. • Coca-Cola Europacific (NASDAQ:CCEP) is expected to report earnings for its Fiscal Year... 
Via Benzinga
News headline image
Earnings Outlook For Bio-Rad Laboratories ↗
 
Via Benzinga
News headline image
Why Atlassian Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Gainers 
Via Benzinga
News headline image
Bio-Rad to Report First Quarter 2023 Financial Results on Thursday, May 4, 2023
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
The 3 Most Promising Biotech Stocks to Buy Now ↗
With the NIH requesting its biggest budget yet, these are the three most promising healthcare stocks to buy now. 
Via InvestorPlace
News headline image
I Asked ChatGPT for 10 EV Stocks to Buy. Here’s What It Recommended. ↗
What are the best EV stocks to buy? ChatGPT has different answers, depending on how it is asked. Here's what investors need to know. 
Via InvestorPlace
News headline image
Bio-Rad to Participate in Citi’s 2023 Healthcare Services, MedTech, Tools & HCIT Conference
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Bio-Rad Reports Fourth-Quarter and Full-Year 2022 Financial Results
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Cytek® Biosciences Partners with Bio-Rad to Expand Reagent Portfolios
New Agreement Enhances High-Parameter Panels on Cytek Cell Analysis Systems 
From Cytek Biosciences, Inc.
Via GlobeNewswire
News headline image
Catalent Hits Four-Month High As Danaher Reportedly Mulls A Takeover ↗
Danaher is reportedly looking to add to its wheelhouse to compete with Thermo. 
Via Investor's Business Daily
News headline image
Thoughts For Thursday: All Eyes On The CPI ↗
All eyes are on the release of the December Consumer Price Index data later today. 2023 has started as a relatively up year for equities and a continued downward trajectory seems necessary to keep the... 
Via Talk Markets
News headline image
Bio-Rad to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 16, 2023
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Bio-Rad to Present Company Overview at J.P. Morgan 41st Annual Healthcare Conference
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Bio Rad Has Almost 40% Upside On Revenue Acceleration And Margin Improvement, Analyst Says ↗
 
Via Benzinga
News headline image
Bio-Rad To Participate in Fireside Chat During Credit Suisse’s 31st Annual Healthcare Conference
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Bio-Rad Reports Third-Quarter 2022 Financial Results
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
  During Friday, 125 stocks hit new 52-week lows. 
Via Benzinga
News headline image
Bio-Rad to Report Third Quarter 2022 Financial Results on Thursday, October 27, 2022
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Why Bio-Rad Laboratories' Rumored $10 Billion Qiagen Buyout Looks Unlikely ↗
One analyst doubts any deal could come to fruition. If it did, it would make sense. 
Via Investor's Business Daily
News headline image
Twitter May Drop Clickable Hashtags, AstraZeneca's Nasal COVID-19 Vaccine Fails Trial, Coinbase Gets Singapore Nod: Top Stories Tuesday, Oct. 11 ↗
Reuters US-China Chip War: KLA Relaxes Chip Supply To China 
Via Benzinga
News headline image
Bio-Rad Laboratories, Qiagen Mull Merger Of Equals ↗
Bio-Rad Laboratories Inc (NYSE: BIO) is reportedly in talks to merge with Qiagen NV (NYSE: QGEN), but any agreement isn't likely for another few weeks or more, or it may not happen at all. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Bio-Rad Acquires Curiosity Diagnostics
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Bio-Rad Laboratories: Q2 Earnings Insights ↗
Bio-Rad Laboratories (NYSE:BIO) reported its Q2 earnings results on Thursday, July 28, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >